VivoSeq
Other

Critical Illness

5

Pipeline Programs

13

Active Trials

3

Companies Involved

Critical Illness is an early-stage landscape with 5 programs across 3 companies. The most active players are Neurim Pharmaceuticals Ltd., Fresenius, David T Huang. 5 therapies are approved.

Pipeline Metrics

Competitive Density

38/100

Pipeline Velocity

34/100

Mech. Concentration

50/100

Completion Rate

79/100

Attrition Rate

7/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Trial Status

29

clinical trials

Completed11 · 38%
Not yet recruiting6 · 21%
Recruiting4 · 14%
Active, not recruiting3 · 10%
Unknown status2 · 7%
Terminated2 · 7%
Other1 · 3%

Trial Activity

29 trials

Delirium Evaluation With Longitudinal Tau Assessment
Recruiting·SScripps Health·N/A·NCT07694206·100 enrolled
Long Term Outcomes of Patients With COVID-19
Active, not recruiting·UUniversity of Chicago·N/A·NCT04360538·500 enrolled
Real-time Evaluation of an Outlier-based Alerting System
Active, not recruiting··Preclinical·NCT06996626·7,445 enrolled
The Effect of Thiamine vs. Placebo on VO2 in Critical Illness
Completed··Phase 2·NCT01985685·66 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)